Brent Satterfield

Track

Insider profile

Currently holds a position at Co-Diagnostics Inc

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 65% 8.2% 15.1%
Success rate 55% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Scientific Officer Co-Diagnostics Inc April 24, 2019 -
Chief Science Officer, Director Co-Diagnostics Inc April 1, 2013 - April 24, 2019
Brent Satterfield's trades of Co-Diagnostics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
220.99
Quantity 42,385 +44.4%
Value US$2,242,657
Transaction date
Purchase
Price
456.23
Quantity 24,337 -14.8%
Value US$49,421
Transaction date
Purchase
Price
110.45
Quantity 86,080 -44.2%
Value US$3,797,149
Transaction date
Purchase
Price
4,920.00
Quantity 2,400 +0.1%
Value US$11,808,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2018-05-15 2018-05-11
B Purchase
42,385 +44.4%
220.99
US$2,242,657 		42,385 +44.4% 220.99 US$2,242,657
2018-04-24 2018-04-23
B Purchase
24,337 -14.8%
456.23
US$49,421 		24,337 -14.8% 456.23 US$49,421
2018-04-16 2018-04-16
B Purchase
86,080 -44.2%
110.45
US$3,797,149 		86,080 -44.2% 110.45 US$3,797,149
2018-04-10 2018-04-09
B Purchase
2,400 +0.1%
4,920.00
US$11,808,000 		2,400 +0.1% 4,920.00 US$11,808,000